top of page
Our Chairman Tony de Fougerolles discusses innate immune rejuvenation
Chairman of LIfT BioSciences, to explore the concept of innate immune rejuvenation – a central pillar of our approach to overcoming...
May 28, 2025
LIfT BioSciences presents preclinical data on its first-in-class Immunomodulatory Alpha Neutrophils at American Society of Gene & Cell Therapy 28th Annual Meeting
showcasing its versatility in diseases beyond oncology London, 22 May 2025– LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly...
May 22, 2025
LIfT BioSciences presents latest data on its first-in-class Immunomodulatory Alpha Neutrophils at International Society for Cell and Gene Therapy
London, 19 May 2025– LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech and the global leader in neutrophil...
May 19, 2025
bottom of page